MYND Life Sciences Inc. (CNSX:MYND) entered into a non-binding letter of intent to acquire Cava Healthcare Inc. on October 25, 2023. The proposed merger will be preceded by independent third-party valuations of both companies. Arrangements within each company will be negotiated by subcommittees of unconflicted Directors from both CAVA and MYND and it will require affirmative votes by the Boards of Directors of both companies.

With respect to the proposed merger with Cava Healthcare, the Board of Directors of MYND Life Sciences formed a Special Committee to review the proposed transaction. It is anticipated the transaction will be completed in Q1 2024.